[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578621":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":34,"responsibleParty":53,"collaborators":55,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":73,"sex":74,"minAge":75,"maxAge":19,"enrollmentInfo":76,"targetDuration":19,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":85,"overallStatus":37,"whyStopped":19,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"VASCage GmbH","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Health promotion arm","EXPERIMENTAL","Over a time period of 12 months participants will receive regular newsletters as part of the health promotion program, informing them about vascular health promotion opportunities in the region. At the end of the study participants are provided with tailored guidance on further optimizing their vascular health to reduce individual risks of stroke and heart attack.",[13],"Other: In-person health promotion",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"In-person health promotion","The results from the initial pre-baseline examination are reviewed during the baseline visit to identify potential risk factors related to the Life's Essential 8 (LE8). Based on these findings, participants receive personalized recommendations to enhance their vascular health and information on local vascular health promotion resources. Additionally, participants receive bi-monthly motivational newsletters designed to support ongoing vascular health improvements.",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Dr.med. Lukas Mayer-Süß, PhD","Medical University Innsbruck","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":19,"email":30},"Muriel Harloff, MSc","CONTACT","+ 43 51255443513","muriel.harloff@vascage.at",{"name":32,"role":28,"phone":29,"phoneExt":19,"email":33},"Petr Simurda, MD","petr.simurda@vascage.at",[35],{"facility":36,"status":37,"city":38,"state":19,"zip":19,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Medical University Innsbruck - Department of Neurology","RECRUITING","Innsbruck","Austria","AT",{"type":42,"coordinates":43},"Point",[44,45],11.39454,47.26266,{"lat":45,"lon":44},[48,52],{"name":49,"role":28,"phone":50,"phoneExt":19,"email":51},"Lukas Mayer-Süß, Dr.med.","+43 512 504 83127","lukas.mayer@i-med.ac.at",{"name":49,"role":24,"phone":19,"phoneExt":19,"email":19},{"type":54,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[56,59,62,64],{"name":57,"class":58},"Oroboros Instruments","UNKNOWN",{"name":60,"class":61},"Med-El Corporation","INDUSTRY",{"name":63,"class":6},"Tirol Kiniken GmbH",{"name":65,"class":58},"Österreichische Gesundheitskasse","100578621","innsbruck-health-promotion-program-100578621",false,"NCT06813677","Innsbruck Health Promotion Program","INNHEALTH","Inclusion Criteria:\n\n* Signed informed consent of subject\n* Main area of residence in Innsbruck and Innsbruck-Land\n\nExclusion Criteria:\n\n* People who are suspended upon a court order or upon other legal processes or are accommodated according ot the Hospitalization Act, or for whom a custodian is appointed (or appointment is inititated)\n* Persons with impaired power of judgement\n* Persons who are currently engaged in military or community service",true,"ALL","18 Years",{"count":77,"type":78},1000,"ESTIMATED","INTERVENTIONAL",[81],"NA","The primary goal of this single-centre. single-arm, unblinded, pre-post interventional study is to evaluate whether a one-time health assessment and intervention affects the overall vascular health evaluated through the Life's Essential 8 overall vascular health score.\n\nSecondary goals of this study are, among others:\n\n* to describe incidence and prevalence of vascular risk-factors and behaviours\n* to explore prevalence and associations of health and disease in the general population with special focus on cardiovascular risk, cardiovascular diseases, markers of vascular health, signs and (prodromal) symptoms of neurodegeneration as well as psychosocial factors\n* to explore the prevalence of hearing disorders in the general population\n* to collect voice and speech samples to identify novel biomarkers that correlate to vascular health and\u002For hearing status",[84],"Assessment of Vascular Health Risk Factors",[86,87,88,89,90,91],"Life's Essential 8","PBMC","Cardiovascular health","Quality of Life","Mitochondrial function","Hearing impairment","2025-11-18",{"date":94,"type":95},"2025-11-19","ACTUAL",{"date":97,"type":95},"2025-05-01",{"date":99,"type":78},"2027-03-31",{"name":5,"class":6},1]